Evidence & policy library
Every pathway is linked to the organizations responsible for the decision.
19 source records
Methodology
Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.
Matching documents: 27
Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
Europe
🇸🇪 SwedenOfficialregulatory authority, current authorisation outputscurrent authority/processLatest observed: 2026-07 decisions
🇸🇪 SwedenOfficialregulatory authority, current authorisation outputscurrent authority/processLatest observed: 2026-07 decisions
🇸🇪 SwedenOfficialdecision owners, ethical principles, region/company reviewcurrent processLatest observed: 2026-01-16
🇸🇪 SwedenOfficialpatient payment and substitution consequencecurrent thresholdsLatest observed: 2025-09-29
🇸🇪 SwedenOfficialreprice, restrict and exclude powerscurrent reassessment processLatest observed: 2026 cases current
🇸🇪 SwedenOfficialthree-party deliberation, side agreements and rebates2026 forecastLatest observed: 2026
🇸🇪 SwedenOfficialTLV assessment without funding decisioncurrent processLatest observed: page current at check
🇸🇪 SwedenOfficialregional mandate and hospital focuscurrent mandateLatest observed: page current at check
🇸🇪 SwedenOfficialdecision factors, publication, validity and revisioncurrent processLatest observed: page current at check
🇸🇪 SwedenOfficialnational-to-regional handoffcurrent implementationLatest observed: page current at check
🇸🇪 SwedenOfficialnational-to-regional handoffcurrent implementationLatest observed: page current at check
🇸🇪 SwedenOfficialHE and multi-factor prioritisationcurrent policyLatest observed: page current at check
🇸🇪 SwedenOfficialregulatory lifecycle and market statuscurrent proceduresLatest observed: 2026-05-26 / 2026-03-31
🇸🇪 SwedenOfficialregulatory lifecycle and market statuscurrent proceduresLatest observed: 2026-05-26 / 2026-03-31
🇸🇪 SwedenOfficialcomplete application and 180-day limitcurrent statutory clockLatest observed: page last updated 2022-08-01
🇸🇪 SwedenOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇸🇪 SwedenOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇸🇪 SwedenOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇸🇪 SwedenOfficialvoluntary participation, initial-application window, readiness dialogue and Letter of Intent milestones2026-08-28Latest observed: 2026-09-07
🇸🇪 SwedenOfficialvoluntary participation, initial-application window, readiness dialogue and Letter of Intent milestones2026-08-28Latest observed: 2026-09-07
🇸🇪 SwedenOfficialinterchangeable-medicine ceiling rules, transitional provisions and separate price decisionsadopted 2026-05-07; printed 2026-06-01; main effect 2026-10-01; chapter 2 section 7 effect 2028-01-01Latest observed: overview 2026-08-31
🇸🇪 SwedenOfficialinterchangeable-medicine ceiling rules, transitional provisions and separate price decisionsadopted 2026-05-07; printed 2026-06-01; main effect 2026-10-01; chapter 2 section 7 effect 2028-01-01Latest observed: overview 2026-08-31
🇸🇪 Sweden
Officialsections 16 and 18: supply confirmation and monthly generic-competition notification cutoff; package annex not applied to individual productsadopted 2026-05-07; printed 2026-06-01; effective 2026-10-01Latest observed: printed 2026-06-01
🇸🇪 Sweden
Officialchapter 2 sections 1-5: new-medicine dossier, JCA non-duplication and conditional simplified applicationadopted 2026-06-11; printed 2026-06-25; effective 2026-10-01Latest observed: printed 2026-06-25
🇸🇪 SwedenOfficialoptional economic template and dossier-category guidance; not a product eligibility decisionapplication rules effective 2026-10-01Latest observed: updated 2026-06-25
🇸🇪 SwedenOfficialEU-level pre-JCA request window, product eligibility, platform deadline and national-reimbursement boundary2025-11-28 annual programme; 2026-09-22 announcementLatest observed: 2026-09-22
🇸🇪 SwedenOfficialEU-level pre-JCA request window, product eligibility, platform deadline and national-reimbursement boundary2025-11-28 annual programme; 2026-09-22 announcementLatest observed: 2026-09-22
For education only — not regulatory, pricing or legal advice.